Cardiology Pathophysiology Quick Notes 1500
$39.99
Buy on Amazon View on Apple BooksPrefer it in print? See every format on Amazon →
Price on Apple Books. Amazon’s price may differ.
- Published
Description
The mechanisms behind modern cardiology, in 1,500 specialist-level notes.
Every decision in cardiology rests on a mechanism. Myosin inhibitors exist because hypercontractile sarcomeres drive hypertrophic cardiomyopathy. SGLT2 inhibitors, neprilysin inhibition and finerenone each act on a defined limb of the cardiorenal axis. Colchicine was tested because inflammation drives plaque instability.
Cardiology Pathophysiology Quick Notes 1500 distils this science into 1,500 numbered notes across 30 chapters. Each note follows one chain of logic: the molecular, cellular or haemodynamic cause, its consequence, and why it matters at the bedside, in the catheter laboratory or on an examination paper.
Inside you will find:
• Ion channels, excitation–contraction coupling and pressure–volume loops
• Coronary flow, endothelial biology, atherogenesis and thrombosis
• Acute coronary syndromes, ischaemia–reperfusion injury, stunning and hibernation
• Ventricular remodelling, neurohormonal activation, HFpEF and cardiorenal physiology
• Shock and ventricular–arterial coupling
• Aortic stenosis, regurgitant lesions and rheumatic mitral disease
• Arrhythmia mechanisms, atrial cardiomyopathy and atrial fibrillation
• Exercise physiology, the athlete's heart and the ageing heart
• Genetic, infiltrative and inflammatory cardiomyopathies
• Tamponade and constriction, the pulmonary circulation and the right ventricle
• Hypertension, aortopathies, congenital shunt and Fontan physiology, and endocarditis
• The heart in systemic disease, pregnancy and cardio-oncology
• Molecular targets and mechanism-based therapeutics
Landmark trials are cited where they validate or refute a mechanism — CANTOS, EXPLORER-HCM, DAPA-HF, PARADIGM-HF and many more.
Written for practising cardiologists and senior fellows preparing for board and fellowship examinations.
About the author: Dr A M Thirugnanam, MD, MSICP, FSCAI, Ph.D., is a Senior Interventional Cardiologist in Hyderabad, India, specialising in CTO PCI, unprotected left main stenting and TAVR, and founder of the Academy of Elite Doctors.